BARD RELEASES SUPPLEMENTAL FINANCIAL DATA.

MURRAY HILL, NJ--(BUSINESS WIRE)--February 9, 1995--C. R. Bard, Inc. (NYSE-BCR) today released additional financial information for the year ended December 31, 1994 as a supplement to the summary data released January 26, 1995.

As indicated in the January 26 summary, sales for the full year 1994 increased 5 percent to $1.018 billion. Net income of $74.9 million was 34 percent above the $56.0 million reported a year earlier. Earnings per share for the year were $1.44, up 35 percent over the $1.07 reported in 1993, with both years including one- time charges. The 1993 results included four one-time items, the net effect of which was a charge to after- tax earnings of 50 cents per share. The 1994 results included a 33 cent per share fourth quarter charge. Adjusting for these events, Bard's net income per share comparison would have been $1.77 versus $1.57, a 13 percent increase.

Bard's gross margin at 51.2 percent was up from 50.9 percent in 1993. Continued emphasis on cost improvement programs coupled with favorable product mix contributed to this improvement. Marketing, selling and administrative expenses were flat year to year, as tight expense controls continued. Research and development expenditures were $69.8 million, up 5 percent over 1993.

Interest expense for 1994 increased to $15.1 million from $11.4 million the previous year. Bard's tax rate in 1994 was 27 percent, down from 37 percent in 1993 resulting primarily from the nonrecurring items.

Bard's financial condition at year-end 1994 remained strong. Cash and short-term investments were $34.2 million, and the Company's total debt to total capitalization ratio equaled 38.4 percent (balance sheet is attached).

Complete financial information will be available in Bard's 1994 Annual Report, scheduled for distribution on March 10.

C. R. Bard, Inc., headquartered in Murray Hill, NJ, is a leading multinational developer, manufacturer and marketer of health care products.

Note: A recorded announcement giving financial performance details for the quarter and the year is available by calling [phone] or 277-8301.

-0-

                       C. R. BARD, INC. AND SUBSIDIARIES
                        STATEMENTS OF CONSOLIDATED INCOME
                      (In thousands except per share figures)

                        For the Quarter Ended     For the Year Ended
                             December 31,           December 31,
                         1994           1993      1994        1993

Net sales                $262,600       $247,000  $1,018,200  $970,800

Costs and expenses:
 Cost of goods sold       128,500        122,100     497,300   476,700

 Marketing, selling
 and administrative        78,700         78,500     300,400   299,300
 Research & development    16,500         14,300      69,800    66,300
                           ------         ------     -------    ------
                          223,700        214,900     867,500   842,300

Operating income           38,900         32,100     150,700   128,500

Interest expense            5,500          3,200      15,100    11,400
Other income (expense),
 net                      (29,800)        33,600     (32,600)  (18,200)

Income before taxes and
 effect of accounting
 change                     3,600         62,500     103,000    98,900

Income tax provision/
 (benefit)                 (2,400)        22,400      28,100    36,800

Income before effect of
 accounting change          6,000         40,100      74,900    62,100

Effect of change in
 accounting principle,
 net of taxes                 ---            ---         ---    (6,100)

Net income                 $6,000        $40,100     $74,900   $56,000

Net income per share
 before effect of
 accounting change           $.11           $.77       $1.44     $1.19

Net income per share         $.11           $.77       $1.44     $1.07

Average shares outstanding                            52,005    52,197

Note: Reflected in the fourth quarter ended December 31, 1994 is a
33 cent per share charge for the settlement of a lawsuit and for
other costs related to Bard's USCI division.  During the fourth
quarter ended December 31, 1993, the Company recognized a one-time
gain of 37 cents per share from the sale of its Ventritex, Inc.
common stock holdings.

-0-

                      C. R. BARD, INC. AND SUBSIDIARIES
                    CONDENSED CONSOLIDATED BALANCE SHEETS
                           (Thousands of dollars)

                               December 31,     December 31,
                                  1994              1993

Assets

Cash and short-term investments   $34,200           $75,000

Accounts receivable(net)          187,300           167,300

Inventories                       199,200           173,500

Other current assets                7,300             5,700

Total current assets              428,000           421,500

Long-term investments              13,300            17,700

Property, plant and equipment
 (net)                            199,900           168,900

Other assets                      317,200           190,500

TOTAL ASSETS                     $958,400          $798,600

Liabilities and Shareholders' Investment

Short-term debt                 $195,900            $84,500

Accounts payable                  39,200             39,300

Accrued liabilities              129,500            140,500

Total current liabilities        364,600            264,300

Long-term debt                    78,300             68,500

Other long-term liabilities       75,700             82,700

Shareholders'investment          439,800            383,100

TOTAL LIABILITIES AND SHAREHOLDERS'
 INVESTMENT                     $958,400           $798,600

-0-

CONTACT: E. L. Parker

C.R. Bard, Inc.

[phone]